Home / Intelligence / White Papers / Why you should consider Patient Finding for physician targeting
Patient Finding is an innovative tool to improve customer targeting that can be implemented fairly quickly, without a lot of organizational disruption, retraining, or complex data integration. It is a worthwhile addition to your portfolio of targeting methods.
For appropriate brands, Patient Finding can provide a significant competitive advantage. As it becomes more widely used by the pharma industry, late adopters may find themselves at a competitive disadvantage.
Complete the form below to access “Why you should consider Patient Finding for physician targeting”
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Webinars
The Future of Patient Finding
November 13, 2024 | 1:00 – 1:45 PM ET
Two additional sessions will be offered: November 14 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai November 14 – 15:00 – 15:45 CET – Europe/Berlin Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient […]
Sign Up Now
Blog
Can GenAI be Used to Improve Data Operations Efficiency?
The short answer is yes, by powering process automation with GenAI. It’s an approach that hasn’t received as much attention as other GenAI use cases within life sciences, but the results can be very powerful. To illustrate its power, we’ll examine a case study on identifying debarred healthcare professionals (HCPs). Why is it important to […]
Read More
Case Studies
Improving Data Operations Efficiency through GenAI-Powered Process Automation
The Situation Pharmaceutical companies are mandated to cease all forms of engagement with debarred healthcare professionals (HCPs) in the U.S. Compliance entails identifying and flagging HCPs from lists periodically released by government agencies. These agencies also issue exclusion notices that call out HCPs whomight be confused with debarred HCPs due to similar names and/or other […]
Read More